These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 26634173)

  • 1. Enhancement of Solubility of Lamotrigine by Solid Dispersion and Development of Orally Disintegrating Tablets Using 3(2) Full Factorial Design.
    Singh J; Garg R; Gupta GD
    J Pharm (Cairo); 2015; 2015():828453. PubMed ID: 26634173
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Design, Optimization and Evaluation of Orally Disintegrating Tablet of Meloxicam Using Its Menthol Based Solid Dispersions.
    Dehghani H; Taheri A; Homayouni A
    Curr Drug Deliv; 2017; 14(5):709-717. PubMed ID: 27142108
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Influence of sodium starch glycolate, croscarmellose sodium and crospovidone on disintegration and dissolution of stevia-loaded tablets.
    Yousaf AM; Naheed F; Shahzad Y; Hussain T; Mahmood T
    Polim Med; 2019; 49(1):19-26. PubMed ID: 31756060
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Microwave-Assisted Development of Orally Disintegrating Tablets by Direct Compression.
    Kande KV; Kotak DJ; Degani MS; Kirsanov D; Legin A; Devarajan PV
    AAPS PharmSciTech; 2017 Aug; 18(6):2055-2066. PubMed ID: 27995465
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Orally-disintegrating Tablets in Fixed-dose Combination Containing Ambroxol Hydrochloride and Salbutamol Sulphate Prepared by Direct Compression: Formulation Design, Development and
    Sharma D; Singh R; Singh G
    Turk J Pharm Sci; 2018 Apr; 15(1):29-37. PubMed ID: 32454637
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Curcumin- β-Cyclodextrin Molecular Inclusion Complex: A Water-Soluble Complex in Fast-dissolving Tablets for the Treatment ofNeurodegenerative Disorders.
    Mugundhan SL; Balasubramaniyan P; Narayanasamy D; Mohan M
    Pharm Nanotechnol; 2024; 12(4):365-377. PubMed ID: 38192139
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Formulation, in vitro characterization and optimization of taste-masked orally disintegrating co-trimoxazole tablet by direct compression.
    Tafere C; Yilma Z; Abrha S; Yehualaw A
    PLoS One; 2021; 16(3):e0246648. PubMed ID: 33725014
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of a superdisintegrant on disintegration of orally disintegrating tablets determined by simulated wetting test and
    Sutthapitaksakul L; Thanawuth K; Huanbutta K; Sriamornsak P
    Pharmazie; 2022 Oct; 77(10):287-290. PubMed ID: 36273260
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Formulation and evaluation of rapidly disintegrating fenoverine tablets: effect of superdisintegrants.
    Battu SK; Repka MA; Majumdar S; Madhusudan RY
    Drug Dev Ind Pharm; 2007 Nov; 33(11):1225-32. PubMed ID: 18058319
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Optimized furosemide taste masked orally disintegrating tablets.
    Ibrahim MA; Abou El Ela AESF
    Saudi Pharm J; 2017 Nov; 25(7):1055-1062. PubMed ID: 29158715
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Design, Formulation, and Physicochemical Evaluation of Montelukast Orally Disintegrating Tablet.
    Aslani A; Beigi M
    Int J Prev Med; 2016; 7():120. PubMed ID: 27857833
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A Comparative Study of Different Proportions of Superdisintegrants: Formulation and Evaluation of Orally Disintegrating Tablets of Salbutamol Sulphate.
    Kumar A; Saharan VA
    Turk J Pharm Sci; 2017 Apr; 14(1):40-48. PubMed ID: 32454593
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Formulation studies for mirtazapine orally disintegrating tablets.
    Yıldız S; Aytekin E; Yavuz B; Bozdağ Pehlivan S; Ünlü N
    Drug Dev Ind Pharm; 2016; 42(6):1008-17. PubMed ID: 26530146
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Formulation and characterization of oral rapid disintegrating tablets of levocetirizine.
    Samvedna S; Jindal S; Mishra G; Madan JR; Gupta G; Awasthi R; Pinto TJA; Dua K; Kulkarni GT
    Polim Med; 2018; 48(1):31-40. PubMed ID: 30657656
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Formulation and evaluation of fast dissolving tablets of cinnarizine using superdisintegrant blends and subliming material.
    Basu B; Bagadiya A; Makwana S; Vipul V; Batt D; Dharamsi A
    J Adv Pharm Technol Res; 2011 Oct; 2(4):266-73. PubMed ID: 22247895
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Formulation and evaluation of rizatriptan benzoate mouth disintegrating tablets.
    Keny RV; Desouza C; Lourenco CF
    Indian J Pharm Sci; 2010 Jan; 72(1):79-85. PubMed ID: 20582194
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Formulation of Ebastine Fast-Disintegrating Tablet Using Coprocessed Superdisintegrants and Evaluation of Quality Control Parameters.
    Dhakal B; Thakur JK; Mahato RK; Rawat I; Rabin DC; Chhetri RR; Shah KP; Adhikari A; Pandey J
    ScientificWorldJournal; 2022; 2022():9618344. PubMed ID: 35645632
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Formulation and evaluation of clozapine orally disintegrating tablets prepared by direct compression.
    Olmez SS; Vural I; Sahin S; Ertugrul A; Capan Y
    Pharmazie; 2013 Feb; 68(2):110-6. PubMed ID: 23469682
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development of orally disintegrating tablets of Perphenazine/hydroxypropyl-β-cyclodextrin inclusion complex.
    Wang L; Zeng F; Zong L
    Pharm Dev Technol; 2013; 18(5):1101-10. PubMed ID: 22759202
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development and evaluation of orally disintegrating tablets of cilostazol-β-cyclodextrin inclusion complexes.
    Desai C; Prabhakar B
    Drug Dev Ind Pharm; 2015; 41(10):1589-607. PubMed ID: 25350555
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.